{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T14:29:55Z","timestamp":1747319395749},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,12,15]]},"DOI":"10.2169\/internalmedicine.0190-22","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T22:19:02Z","timestamp":1664921942000},"page":"3651-3658","source":"Crossref","is-referenced-by-count":3,"title":["Timeline of Oxygen Demand in Patients with COVID-19 Pneumonia"],"prefix":"10.2169","volume":"61","author":[{"given":"Tsuneyuki","family":"Oda","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Yamaya","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497-506, 2020.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323: 1061-1069, 2020.","DOI":"10.1001\/jama.2020.1585"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc 18: 799-806, 2021.","DOI":"10.1513\/AnnalsATS.202008-1002OC"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bieksiene K, Zaveckiene J, Malakauskas K, Vaguliene N, Zemaitis M, Miliauskas S. Post COVID-19 organizing pneumonia: the right time to interfere. Medicina 57: 2021.","DOI":"10.3390\/medicina57030283"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chong WH, Saha BK, Chopra A. Does COVID-19 pneumonia signify secondary organizing pneumonia?: a narrative review comparing the similarities between these two distinct entities. Heart Lung 50: 667-674, 2021.","DOI":"10.1016\/j.hrtlng.2021.04.009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 20: 425-434, 2020.","DOI":"10.1016\/S1473-3099(20)30086-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fu F, Lou J, Xi D, et al. Chest computed tomography findings of coronavirus disease 2019 (COVID-19) pneumonia. Eur Radiol 30: 5489-5498, 2020.","DOI":"10.1007\/s00330-020-06920-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Vad\u00e1sz I, Husain-Syed F, Dorfm\u00fcller P, et al. Severe organising pneumonia following COVID-19. Thorax 76: 201-204, 2021.","DOI":"10.1136\/thoraxjnl-2020-216088"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8: 475-481, 2020.","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wang F, Qu M, Zhou X, et al. The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China. J Transl Med 18: 270, 2020.","DOI":"10.1186\/s12967-020-02423-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zayet S, Gendrin V, Klopfenstein T. Natural history of COVID-19: back to basics. New Microbes New Infect 38: 100815, 2020.","DOI":"10.1016\/j.nmni.2020.100815"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384: 693-704, 2021.","DOI":"10.1056\/NEJMoa2021436"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ranjbar K, Moghadami M, Mirahmadizadeh A, et al. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis 21: 337, 2021.","DOI":"10.1186\/s12879-021-06045-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pinz\u00f3n MA, Ortiz S, Holgu\u00edn H, et al. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia. PLoS One 16: e0252057, 2021.","DOI":"10.1371\/journal.pone.0252057"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. L\u00f3pez Z\u00fa\u00f1iga M, Moreno-Moral A, Oca\u00f1a-Granados A, et al. High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response. PLoS One 16: e0243964, 2021.","DOI":"10.1371\/journal.pone.0243964"},{"key":"16","unstructured":"16. Jeronimo CMP, Farias MEL, Val FFA, et al.; the Metcovid Team. Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb, placebo-controlled trial. Clin Infect Dis 72: e373-e381, 2021."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Khokher W, Beran A, Iftikhar S, et al. Pulse versus nonpulse steroid regimens in patients with coronavirus disease 2019: a systematic review and meta-analysis. J Med Virol 94: 4125-4137, 2022.","DOI":"10.1002\/jmv.27824"},{"key":"18","unstructured":"18. Salvarani C, Massari M, Costantini M, et al. Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia, A double-blind, randomised, placebo-controlled trial. Eur Respir J. Forthcoming."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Izumo T, Kuse N, Awano N, et al. Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19. Respir Investig 59: 799-803, 2021.","DOI":"10.1016\/j.resinv.2021.07.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Abu-Raddad LJ, Chemaitelly H, Butt AA. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. N Engl J Med 385: 187-189, 2021.","DOI":"10.1056\/NEJMc2104974"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/24\/61_0190-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T03:23:00Z","timestamp":1671247380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/24\/61_0190-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":20,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0190-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"article-number":"0190-22"}}